Aliskiren

Aliskiren
(IUPAC) ime
	(2S,4S,5S,7S)-5-amino-N-(2-karbamoil-2,2-dimetiletil)-4-hidroksi-7[4-metoksi-3-(3-metoksipropoksi)fenil]metil8-metil-2-(propan-2-il)nonanamid
Klinički podaci
AHFS/Drugs.com	Monografija
MedlinePlus	a607039
Identifikatori
CAS broj	173334-57-1
ATC kod	C09XA02 ; C09XA52 (sa HCT)
PubChem	5493444
DrugBank	DB01258
ChemSpider	4591452
UNII	502FWN4Q32
KEGG	D03208
ChEBI	CHEBI:601027
ChEMBL	CHEMBL1639
Hemijski podaci
Formula	C30H53N3O6
Mol. masa	551,758 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C30H53N3O6/c1-19(2)22(14-21-10-11-26(38-8)27(15-21)39-13-9-12-37-7)16-24(31)25(34)17-23(20(3)4)28(35)33-18-30(5,6)29(32)36/h10-11,15,19-20,22-25,34H,9,12-14,16-18,31H2,1-8H3,(H2,32,36)(H,33,35)/t22-,23-,24-,25-/m0/s1 ; Key: UXOWGYHJODZGMF-QORCZRPOSA-N
Farmakokinetički podaci
Bioraspoloživost	niska (oko 2,5%)
Metabolizam	Hepatički, CYP3A4-posredovano
Poluvreme eliminacije	24 sata
Izlučivanje	Renalno
Farmakoinformacioni podaci
Licenca	EU EMEA:link, US FDA:link
Trudnoća	?
Pravni status	POM (UK) ℞-only (SAD)
Način primene	PO (oralno)

Aliskiren (Tekturna (SAD); Rasilez (UK i druge zemlje)) prvi je u klasi lekova koji se nazivaju direktnim reninskim inhibitorima. Njegova trenutna licencirana indikacija je primarna hipertenzija.

Aliskiren su razvila preduzeća Novartis i Speedel.^[6]^[7] On je odobren u SAD 2007. za tretman primarne hipertenzije.

Osobine[uredi | uredi kod]

Osobina	Vrednost
Broj akceptora vodonika	7
Broj donora vodonika	4
Broj rotacionih veza	19
Particioni koeficijent^[8] (ALogP)	3,3
Rastvorljivost^[9] (logS, log(mol/L))	-7,5
Polarna površina^[10] (PSA, Å²)	146,1

Reference[uredi | uredi kod]

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
↑ Gradman A, Schmieder R, Lins R, Nussberger J, Chiang Y, Bedigian M (2005). „Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients”. Circulation 111 (8): 1012–8. DOI:10.1161/01.CIR.0000156466.02908.ED. PMID 15723979.
↑ Straessen JA, Li Y, and Richart T (2006). „Oral Renin Inhibitors”. Lancet 368 (9545): 1449–56. DOI:10.1016/S0140-6736(06)69442-7. PMID 17055947.
↑ Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o.
↑ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573.
↑ Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286.

Spoljašnje veze[uredi | uredi kod]

	Portal Medicina
	Portal Hemija

Prescribing Information for Tekturna Arhivirano 2011-07-20 na Wayback Machine-u
MeSH aliskiren
Chemical synthesis

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

[4] Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.

[5] Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

[6] Gradman A, Schmieder R, Lins R, Nussberger J, Chiang Y, Bedigian M (2005). „Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients”. Circulation 111 (8): 1012–8. DOI:10.1161/01.CIR.0000156466.02908.ED. PMID 15723979.

[7] Straessen JA, Li Y, and Richart T (2006). „Oral Renin Inhibitors”. Lancet 368 (9545): 1449–56. DOI:10.1016/S0140-6736(06)69442-7. PMID 17055947.

[8] Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o.

[9] Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573.

[10] Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

Aliskiren

Osobine[uredi | uredi kod]

Reference[uredi | uredi kod]

Spoljašnje veze[uredi | uredi kod]

Navigacija

Pretraga